Dr Farzana Rahman Momo, M Phil (Biochemistry) Final Part Student, Mymensingh Medical College (MMC), Mymensingh, Bangladesh; E-mail:
Mymensingh Med J. 2024 Oct;33(4):955-961.
Obesity is a major global health issue and WHO points out that 1 in 3 people globally is clinically obese. Obesity is a condition of having an excessive amount of body fat and is linked with several health disorders that include metabolic syndrome, cardiovascular diseases as well as liver diseases. Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are usually used to assess liver function. It is established that obesity results in many cases of liver disorders known as steatosis or non-alcoholic fatty liver disease (NAFLD). It is the excessive deposit of fat within the liver cells that may result in inflammation, fibrosis and cirrhosis. Studies on obesity have established that obese subjects significantly tend to have higher liver enzymes like ALT and AST than non-obese adults. This study aims to compare these two liver enzymes between these two groups in the hopes of shedding light on how obesity impacts the liver and offers these biomarkers for NAFLD. The study was designed to assess the status of liver function in adult obese individuals by examining key markers, including serum Alanine Aminotransferase (ALT) and Aspartate Aminotransferase (AST), and to compare them with non-obese adults. The present cross-sectional study was carried out in the Department of Biochemistry, Mymensingh Medical College, Mymensingh, in collaboration with the Department of Endocrinology and Medicine, Mymensingh Medical College Hospital, from Octy 2023 to June 2024. The subjects were selected based on inclusion and exclusion criteria by purposive non-random sampling. A total of 200 participants took part in this study. Out of them, 100 were selected as case (obese adults) and another 100 non-obese adults were selected as control. In this study, serum ALT and AST levels were measured for analytical study. All the values were expressed as mean±SD. Statistical analysis was done using by using SPSS Windows package version 26.0. The statistical significance of the difference between the case and control was calculated using Student's unpaired 't'- test. Pearson's correlation is done to see the level of significance. After careful evaluation, the mean±SD values of serum ALT were 37.14±15.18 U/L and 21.92±5.10 U/L in case and control groups respectively, and mean±SD values of serum AST were 41.15±15.24 U/L and 25.01±6.65 U/L in case and control group respectively. This study revealed that mean serum ALT and AST levels were significantly increased in obese adults. There was a significant positive correlation found between BMI with serum ALT and AST levels. Analyzing the findings of this cross-sectional study, significant alterations in serum ALT and AST levels were observed among obese adults.
肥胖是一个全球性的主要健康问题,世界卫生组织指出,全球有 1/3 的人患有临床肥胖症。肥胖是一种体内脂肪过多的状况,与多种健康障碍有关,包括代谢综合征、心血管疾病和肝脏疾病。丙氨酸氨基转移酶(ALT)和天冬氨酸氨基转移酶(AST)通常用于评估肝功能。已经确定肥胖会导致许多称为脂肪变性或非酒精性脂肪性肝病(NAFLD)的肝脏疾病。这是肝内细胞内脂肪的过度沉积,可能导致炎症、纤维化和肝硬化。肥胖的研究已经证实,肥胖患者的 ALT 和 AST 等肝酶水平明显高于非肥胖成年人。本研究旨在比较这两组人群中这两种肝酶的水平,以期阐明肥胖对肝脏的影响,并为 NAFLD 提供这些生物标志物。该研究旨在通过检查关键标志物,包括血清丙氨酸氨基转移酶(ALT)和天冬氨酸氨基转移酶(AST),评估成年肥胖个体的肝功能状况,并将其与非肥胖成年人进行比较。本横断面研究于 2023 年 10 月至 2024 年 6 月在孟加拉国迈门辛医科大学生物化学系与迈门辛医科大学医院内分泌学和医学系合作进行。通过目的非随机抽样选择符合纳入和排除标准的受试者。共有 200 名参与者参加了这项研究。其中,100 人被选为病例(肥胖成年人),另外 100 名非肥胖成年人被选为对照组。在这项研究中,测量了血清 ALT 和 AST 水平进行分析研究。所有值均表示为均数±标准差。使用 SPSS Windows 包版本 26.0 进行统计分析。使用学生非配对“t”-检验计算病例和对照组之间差异的统计学意义。进行 Pearson 相关性分析以确定显著性水平。经过仔细评估,病例组和对照组的血清 ALT 均值±标准差分别为 37.14±15.18 U/L 和 21.92±5.10 U/L,血清 AST 均值±标准差分别为 41.15±15.24 U/L 和 25.01±6.65 U/L。本研究表明,肥胖成年人的血清 ALT 和 AST 水平显著升高。BMI 与血清 ALT 和 AST 水平之间存在显著正相关。分析这项横断面研究的结果,观察到肥胖成年人的血清 ALT 和 AST 水平发生了显著变化。